Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - valaciclovir hydrochloride monohydrate -

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - valaciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; crospovidone; magnesium stearate; indigo carmine aluminium lake; titanium dioxide; hypromellose; polysorbate 80; macrogol 6000; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. treatment of ophthalmic zoster. treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes in immunocompromised patients with creatinine clearance of > 15 ml/min. for the reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valaciclovir, it is recommended that patients use safer sex practices (see precautions). for prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - valaciclovir hydrochloride monohydrate 1223.4mg equivalent to valaciclovir base 1000 mg - film coated tablet - 1000 mg - active: valaciclovir hydrochloride monohydrate 1223.4mg equivalent to valaciclovir base 1000 mg excipient: magnesium stearate microcrystalline cellulose opadry white y-5-7068 povidone - valaciclovir actavis is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - valaciclovir hydrochloride monohydrate 305.85mg equivalent to valaciclovir base 250 mg - film coated tablet - 250 mg - active: valaciclovir hydrochloride monohydrate 305.85mg equivalent to valaciclovir base 250 mg excipient: magnesium stearate microcrystalline cellulose opadry white y-5-7068 povidone - valaciclovir actavis is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - valaciclovir hydrochloride monohydrate 611.7mg equivalent to valaciclovir base 500 mg - film coated tablet - 500 mg - active: valaciclovir hydrochloride monohydrate 611.7mg equivalent to valaciclovir base 500 mg excipient: magnesium stearate microcrystalline cellulose opadry white y-5-7068 povidone - valaciclovir actavis is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.

Իսրայել - անգլերեն - Ministry of Health

glaxo smith kline (israel) ltd - valaciclovir as hydrochloride - film coated tablets - valaciclovir as hydrochloride 500 mg - valaciclovir - valaciclovir - varicella zoster virus (vzv) infections – herpes zoster:valtrex is indicated for the treatment of herpes zoster (shingles) and ophthalmic zoster in immunocompetent adults.valtrex is indicated for the treatment of herpes zoster in adult patients with mild or moderate immunosuppression.herpes simplex virus (hsv) infections:valtrex is indicated for the treatment and suppression of hsv infections of the skin and mucous membranes including- treatment of first-episode of genital herpes in immunocompetent adults and adolescents and in immunocompromised adults- treatment of recurrences of genital herpes in immunocompetent adults and adolescents, and in immunocompromised adults- suppression of recurrent genital herpes in immunocompetent adults and adolescents and in immunocompromised adultstreatment and suppression of recurrent ocular hsv infections in immunocompetent adults and adolescents and in immunocompromised adults clinical studies have not been conducted in hsv-infected patients immunocompromised for other causes than hiv-infection.cytomegalovirus (cmv) infections:valtrex is indicated for the prophylaxis of cmv infection and disease following solid organ transplantation in adults and adolescents

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - valaciclovir hydrochloride monohydrate - film coated tablet - 500 milligram - nucleosides and nucleotides excl. reverse transcriptase inhibitors

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - valaciclovir hydrochloride - oral tablet - 500mg

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - valaciclovir hydrochloride - oral tablet - 500mg

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - valaciclovir hydrochloride - oral tablet - 250mg